ABSTRACT
Genotypic variables

177
For the ClinSeq R cohort, SNP genotyping was performed using the HumanOmni2.5 Illumina BeadChip BeadChips incorporates around 2.5 million markers. GenomeStudio output files were processed using a 186 custom Perl script to derive the nucleotides at each SNP position for each subject.
187
For the FHS cohort, genotyping data was compiled from three resources. More than 276,000 variants in 503,551 SNPs with successful call rate >95% and Hardy-Weinberg equilibrium (HWE) P>1.0E-6.
193
Additional genotype imputation was conducted based on this SHARe data using Minimac with reference Best-guessed genotypes with imputation quality >0.3 were used for markers that were not available from 196 the first two actual genotyping platforms.
197
We compiled a set of 57 SNPs (listed in Table S4 ) that were associated with coronary calcium in SNPs in both SNP sets were coded as 0 or 2 (homozygous for either allele) or 1 (heterozygous) using the 203 same reference alleles in both ClinSeq R and FHS cohorts.
204
Predictive modeling using random forests and neural networks 205 We implemented the random forest classification method using the Statistics and Machine Learning predictive patterns generated by data from the ClinSeq R discovery cohort were also compared with the 235 patterns generated by the independent FHS replication cohort. Finally, random forest models were also 236 used to identify a subset of SNPs in SNP Set-2 that generated the optimal predictive performance in both
237
ClinSeq R and FHS cohorts.
238
Upon identifying the subset of SNPs in SNP Set-2 that generate random forest models with optimal 239 performance in both cohorts, we implemented a neural-network-based classification approach using to the design of our study.
275
We next built random forest models for the ClinSeq R discovery cohort using the genotypes of the 57 
281
To compare the predictive patterns generated by the discovery and replication cohorts based on the
282
SNP Set-1 genotype data, we next developed random forest models for the FHS replication cohort and terms, for any SNP within SNP Set-1, a higher correlation between the genotype and the case-control 317 statuses of the 32 subjects led to a higher predictive importance value. Using this rationale, we identified 318 an alternative "SNP Set-2" (56 SNPs not associated with CAC in past studies) whose genotypes had the 319 highest correlation values with the case-control status. Within the ClinSeq R discovery cohort, the range 320 of genotype-phenotype correlation among the SNPs in SNP Set-2 was 0.63-0.73, whereas the same range 321 was 0-0.51 among the SNPs in SNP Set-1. Hence, there was no overlap between the two sets of SNPs.
322
Upon incorporating the genotypes of SNP Set-2 within the ClinSeq R discovery cohort into random 323 forest models, the AUC value turned out to be 0.9975, thereby verifying the superb ability of this set of 324 markers. As shown in Table S8 , 42 of these 56 predictive SNPs have been previously associated with a 325 total of 18 risk factors, whereas the total number of SNP-risk factor pairs was 86 with many individual 326 SNPs being associated with multiple risk factors. This was in contrast to only 11 of the 17 predictive 327 SNPs in SNP Set-1 that were associated with a total of 18 risk factors forming 28 SNP-risk factor pairs.
328
In addition, the susceptibility score, which is computed as the cumulative predictive importance values of 329 SNPs tied to CAD risk factors in previous GWAS, increased from 446 to 1229 aligning with the improved 330 predictive accuracy from 0.72 (maximum AUC in Figure 3B for SNP Set-1 in the ClinSeq R discovery 331 cohort) to ≈1.00 as we moved between the two sets of predictors, namely SNP Set-1 and SNP Set-2. Table S9 shows that ten of the predictive SNPs in Set-2 that have been associated with stroke and aortic 333 valve calcium in past GWAS, a trend we also observe with three SNPs in SNP Set-1 (Table S7) . Two of the 334 predictive SNPs in Table S9 have also been linked to mitral annular calcium, another disease phenotype Comparing predictive performance of SNP Set-2 using FHS and ClinSeq R data sets 340 In order to test whether the higher predictive performance of SNP Set-2 over the past GWAS-based SNP
341
Set-1 was replicated in the FHS cohort, we trained and tested random forest models using the genotypes 
361
One potential explanation of the higher predictive performance of SNP Set-2 over SNP Set-1 in both 362 cohorts is the broad CAC levels that were focused on past GWAS and meta-analyses (instead of highly 363 advanced CAC) in order to reach adequate statistical power. Given that SNP Set-2 was derived from cases 364 with extreme levels of CAC, it remained to be determined whether the predictive power of SNP Set-2 was 365 specific to this extreme phenotype or whether it could be generalized to a broader range of CAC levels. Table 3 shows the list of 21 SNPs in SNP Set-2 generated optimal predictive performance in ClinSeq R We identified a total of 13 genes that included the 21 SNPs leading to optimal predictive performance 389 in both cohorts. Using GeneMANIA, we derived a network that included this group of 13 genes in addition 390 to the 18 genes known to be linked to the first group based on coexpression and genetic interaction data Table S10 . The proteins coded by the genes in 393 the network have a wide range of roles. 12 of them are either a transcription factor or an enzyme, one is a 394 translational regulator, and two are transmembrane receptors.
395
Figure 6. Network derived from GeneMANIA based on 244 studies in humans. The connections in pink are derived from gene coexpression data, whereas the connections in green are derived from genetic interaction data from the literature. The inner circle is composed of genes on which the subset of SNPs in SNP Set-2 leading to optimal performance in both cohorts are present, whereas the genes forming the outer circle are additional genes identified by GeneMANIA. The thicknesses of the links (or edges) between the genes are proportional to the interaction strengths, whereas the node size for each gene is proportional to the rank of the gene based on its importance (or gene score) within the network.
In order to identify whether our list of genes was enriched in any biological functions or processes Database.
405
Through mouse and rat models, six genes in our network have been previously associated with cardio- homeostasis) is associated with mass of adipose tissue, hypoinsulinemia, hyperglycemia, secretion of 413 insulin, rate of oxidation of fatty acid, hyperlipidemia, timing of the onset of hyperglycemia, and diabetes.
414
Similarly, using mouse model-based studies, EGLN1 (involved in the regulation of angiogenesis, oxygen 415 homeostasis, and response to nitric oxide) and its paralog EGLN3 have been linked to the necrosis of 416 heart tissue, apoptosis of cardiomyocytes in infarcted mouse heart, stabilization of HIF1-alpha protein 417 in left ventricle from mouse heart, functional recovery of heart, hepatic steatosis (fatty liver disease), with CAD-related phenotypes (Table S9 ) identified in previous GWAS were all nominally significant 532 contrary to the predictive SNPs from SNP Set-1 derived from past GWAS on CAC, many of which reached 533 genome-wide significance previously in GWAS on CAD-related phenotypes (Table S7 ). In (Björkegren 534 et al., 2015), the recommended approach for predicting CAD and related phenotypes (especially beyond 535 early disease stages) is dividing case subjects into subcategories based on the level of disease measured by 536 imaging or histological measures (measured CAC scores in our study) to identify subphenotype-specific 537 integrative models. We implement a similar approach in our predictive modeling study by just focusing on 538 case subjects within the 89 th -99 th percentile CAC score range and age-matching controls. The replication 539 of the highly predictive loci identified from the ClinSeq R discovery cohort in the FHS cohort and the fact 540 that we observe enrichment of several biological processes previously linked to cardiovascular disease at 541 the network level demonstrates the effectiveness of our machine learning based approach.
542
CONCLUSIONS
543
In this study, we used a combination of clinical and genotype data for predictive modeling of advanced differentiation of adipocytes, were found to be enriched among these loci.
558
A potential extension of our modeling study is the expansion of the panel of SNPs that are highly 559 predictive of advanced coronary calcium levels around their loci for building more comprehensive models.
560
Subsequently, we can assess these loci as predictors of rapid CAC progression and early onset of MI 561 with longitudinal data in independent cohorts, especially for cases poorly predicted by traditional risk nhlbi.org/Calcium/input.aspx).
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